JMP® Genomics, NCGR Partnership to Foster Development of Next-Gen Sequencing Tools
News Nov 07, 2008
A new strategic partnership between SAS and the National Center for Genome Resources (NCGR) will strengthen ongoing collaboration between JMP and NCGR for the co-development of software tools for next-generation sequencing data analysis. The partnership was announced by SAS. JMP is a business unit of SAS.
NCGR is a nonprofit research institute dedicated to improving human health and nutrition through next-gen sequencing, bioinformatics analysis and development of bioinformatics tools. The institute has developed more than a dozen software tools and databases to analyze and store a multitude of biological data types.
In addition, NCGR researchers use JMP® Genomics in scientific research projects ranging from the study of changes in the brains of schizophrenia sufferers to soybean research aimed at finding genetic differences linked to important agronomic traits.
“We have been pleased to see NCGR’s JMP Genomics users apply standard JMP Genomics tools to summarized sequence data sets, and provide us valuable suggestions for enhancements that will shape the software’s capabilities in future versions,” said Russ Wolfinger, Director of Scientific Discovery and Genomics at SAS.
“As a customer, NCGR has worked with the JMP Genomics team to achieve groundbreaking endeavors in this exciting and rapidly changing area of scientific research,” said Faye Schilkey, Associate Director of NCGR’s New Mexico Genome Sequencing Center. “We’ve created an in-house pipeline for aligning and summarizing sequencing data, and JMP Genomics plays a vital role for our scientists, letting us work more quickly and efficiently to explore that data.”
The New Mexico center houses six Illumina Genome Analyzer II sequencers, in addition to other sequence technology platforms, and provides sequencing services to NCGR and external clients. Raw sequence reads are analyzed and filtered by NCGR’s internally developed Alpheus® software system to extract the significant findings.
Alpheus users who also license JMP Genomics can then export their data for further exploration. “The remarkable visualization features of JMP Genomics give us immediate insight into our research findings,” Schilkey said. “Important differences just pop right out.”
“We are very pleased to expand our relationship with NCGR into a partnership with their services group,” said Shannon Conners, JMP Genomics Product Manager. Schilkey was a featured speaker at a successful seminar series in California co-sponsored by JMP Genomics and partner Ingenuity Systems.
In addition to NCGR, Illumina and Ingenuity Systems, JMP Genomics also has partnerships through SAS with InforSense and Affymetrix.
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018